Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

Learn more

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

Conduent Incident Incidente de Conduent

Search

ADD‑E Initiation Phase Scorecards Coming Soon

Date: January 26, 2025

Attention: All Providers

ADD-E Quality


Call to action: Texas Children’s Health Plan (TCHP) would like to inform you that ADD-E-Initiation Phase Prescriber Scorecards will be sent to select providers in the coming weeks. These letters are part of our ongoing commitment to transparency and continuous quality improvement.

What is the ADD-E Measure?

The ADD-E (Follow-Up Care for Children Prescribed ADHD Medication) measure evaluates the percentage of children ages 6–12 who, after being newly prescribed ADHD medication, complete a follow-up visit with a prescribing practitioner within 30 days – the Initiation Phase.

Why This Matters

These review letters provide insight into your performance on the ADD-E measure compared to other providers in the TCHP network. Our goal is to support you in delivering timely, high-quality care, and ensuring appropriate follow-up for children starting ADHD medication.

Recommended Best Practice

To help improve follow-up compliance, TCHP suggests the following approach:

  • Consider starting with a 15-day prescription for newly diagnosed patients.
  • Schedule a telehealth follow-up visit within two weeks.
  • If the follow-up visit confirms the treatment is effective, issue a 30-day prescription going forward.

This approach not only ensures that the child receives proper monitoring but also minimizes the risk of excess stimulant dispensing.

ADD-E Performance Reviews

To continue supporting your work, TCHP is sending Prescriber Scorecard: ADD-E-Initiation Phase letters again soon. This scorecard will:

  • Analyze each prescriber’s compliance with the ADD-E Initiation Phase.
  • Rank providers into quartiles based on follow-up visit completion rates for the prescriptions written under their NPI.
  • Offer personalized insights, peer comparisons, and targeted resources.

Our aim is to empower you with data-driven feedback that enhances adherence, improves treatment outcomes, and enhances patient care.

Please note that individual prescriber rates are not used to determine eligibility to the provider incentive program.

Resources Available to You

Next Steps

We encourage you to:

  • Review your upcoming Prescriber Scorecard: ADD-E-Initiation Phase letter.
  • Share this communication with your clinical and administrative staff.
  • Reach out to your PRL for support in developing improvement strategies.

Thank you for your continued dedication to providing exceptional care to our members, your patients.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org. 

For access to all provider alerts,log into: www.texaschildrenshealthplan.org/provideralerts.